Medpace expects 2026 revenue of $2.805B-$2.885B as it cites a constructive July environment and lower cancellations
Seeking Alpha ·
Earnings Call Insights: Medpace (MEDP) Q2 2026 "The business environment was strong in Q2 2026." (CEO, President & Chairman August Troendle) "Cancellations were well behaved and supported a record quarter for net bookings." (CEO, President & Chairman Troendle)
AI 시장 분석
Medpace (MEDP) projected its full-year 2026 revenue to reach between $2.805 billion and $2.885 billion. A favorable operating environment in July and low cancellation rates supported the achievement of record net new business. This demonstrates the company's solid fundamentals and provides a positive signal to investors.
상승 영향
- Biotechnology — Declining cancellation rates and record-breaking net new business are accelerating earnings growth for Contract Research Organizations (CROs).
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 50% · Bearish (Short) 50%
578 participants
Related News
- Eagle Bancorp forecasts 2026 NIM of 2.6%-2.7% while planning to return to growth in 2027
- Amalgamated targets $338M-$340M 2026 net interest income as assets approach $9.6B
- Tesla Reports $1 Billion Gain On Its SpaceX Equity Stake
- Honeywell targets 3%-4% organic sales growth and $8.20 adjusted EPS midpoint in 2026 as it raises outlook
- WEX outlines 2026 revenue of $2.86B-$2.9B while prioritizing buybacks after leverage returns to 2.9x
- NHTSA starts process for new vehicle door-exit safety requirements
